Chemoinformaics analysis of 24-Methyl-Lanost-9(11)-En-3-Beta-Ol
Molecular Weight | 440.756 | nRot | 4 |
Heavy Atom Molecular Weight | 388.34 | nRig | 21 |
Exact Molecular Weight | 440.402 | nRing | 4 |
Solubility: LogS | -6.235 | nHRing | 0 |
Solubility: LogP | 8.075 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 31 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 87.2452 |
nHD | 1 | BPOL | 52.1668 |
QED | 0.433 |
Synth | 4.748 |
Natural Product Likeliness | 3.3 |
NR-PPAR-gamma | 0.027 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.248 |
Pgp-sub | 0 |
HIA | 0.009 |
CACO-2 | -4.814 |
MDCK | 0.00000825 |
BBB | 0.641 |
PPB | 0.991699 |
VDSS | 3.783 |
FU | 0.0148252 |
CYP1A2-inh | 0.03 |
CYP1A2-sub | 0.395 |
CYP2c19-inh | 0.07 |
CYP2c19-sub | 0.957 |
CYP2c9-inh | 0.093 |
CYP2c9-sub | 0.524 |
CYP2d6-inh | 0.031 |
CYP2d6-sub | 0.437 |
CYP3a4-inh | 0.232 |
CYP3a4-sub | 0.488 |
CL | 18.161 |
T12 | 0.005 |
hERG | 0.011 |
Ames | 0.01 |
ROA | 0.153 |
SkinSen | 0.047 |
Carcinogencity | 0.02 |
EI | 0.016 |
Respiratory | 0.842 |
NR-Aromatase | 0.149 |
Antiviral | No |
Prediction | 0.549733 |